MR1 Antikörper (AA 20-260)
Kurzübersicht für MR1 Antikörper (AA 20-260) (ABIN6143983)
Target
Alle MR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 20-260
-
Sequenz
- SDSRTHSLRY FRLGVSDPIH GVPEFISVGY VDSHPITTYD SVTRQKEPRA PWMAENLAPD HWERYTQLLR GWQQMFKVEL KRLQRHYNHS DNVAHTIKQA WEANQHELLY QKNWLEEECI AWLKRFLEYG KDTLQRTEPP LVRVNRKETF PGVTALFCKA HGFYPPEIYM TWMKNGEEIV QEIDYGDILP SGDGTYQAWA SIELDPQSSN LYSCHVEHCG VHMVLQVPQE SETIPLVMKA V
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 20-260 of human MR1 (NP_001181928.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000,IF,1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- MR1 (Major Histocompatibility Complex, Class I-Related (MR1))
-
Andere Bezeichnung
- MR1
-
Hintergrund
- MAIT (mucosal-associated invariant T-cells) lymphocytes represent a small population of T-cells primarily found in the gut. The protein encoded by this gene is an antigen-presenting molecule that presents metabolites of microbial vitamin B to MAITs. This presentation may activate the MAITs to regulate the amounts of specific types of bacteria in the gut. Several transcript variants encoding different isoforms have been found for this gene, and a pseudogene of it has been detected about 36 kbp upstream on the same chromosome.,MR1,HLALS,Immunology & Inflammation,MR1
-
Molekulargewicht
- 25 kDa/28 kDa/34 kDa/39 kDa
-
Gen-ID
- 3140
-
UniProt
- Q95460
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-